Uso de substâncias psicoativas, alterações vocais e qualidade de vida em usuários de drogas lícitas e ilícitas

Moreira, Taís de Campos; Gadenz, Camila Dalbosco; Figueiró, Luciana Rizzieri; Capobianco, Dirce Maria; Cunha, Karini; Ferigolo, Maristela; Barros, Helena M.T.; Cassol, Mauricéia

doi:10.1590/1982-021620156714

Cited by 14 publications

(4 citation statements)

References 27 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We also observed another association of the presence of voice complaints in the population using alcoholic beverages and we verified this in other studies (18)(19)(20) . Frequent alcohol consumption was associated with laryngeal pathologies (19) and a study with an elderly population found that alcohol concomitant with smoking increased the risk of laryngeal diseases (20) .…”

Section: Discussionsupporting

confidence: 90%

Fatores associados às queixas vocais autorreferidas por agentes comunitários de saúde

Murta

Barbosa

Caldeira

et al. 2021

CoDAS

View full text Add to dashboard Cite

RESUMO Objetivo Verificar a prevalência das queixas vocais e a associação com os fatores sociodemográficos, econômicos, ocupacionais e comportamentais entre a população de Agentes Comunitários de Saúde (ACS). Método Trata-se de um estudo transversal e analítico, realizado no município de Montes Claros, MG, no qual participaram 674 ACS. Para os aspectos sobre o uso da voz foi aplicado o Índice de Triagem de Distúrbio de Voz (ITDV) e os demais dados contemplavam as condições sociodemográficas, econômicas, ocupacionais e comportamentais. Realizou-se a análise bivariada, pelo teste do qui-quadrado de Pearson, e a regressão múltipla de Poisson com variância robusta para verificar a associação entre as variáveis. Resultados Houve alta prevalência de queixas vocais, sendo as mais citadas: garganta seca, pigarro, cansaço ao falar e rouquidão. Verificou-se associação significativa entre: sexo feminino, falta de sono reparador, uso de bebidas alcóolicas, autoavaliação da saúde regular a muito ruim e ansiedade. Conclusão Houve uma porcentagem significativa de queixas vocais e os fatores associados encontrados nortearão ações de promoção da saúde vocal e geral.

show abstract

Section: Discussionsupporting

confidence: 90%

Fatores associados às queixas vocais autorreferidas por agentes comunitários de saúde

Murta

Barbosa

Caldeira

et al. 2021

CoDAS

View full text Add to dashboard Cite

show abstract

“…In the context of this study, a short list of psychiatric medication that may have such side effects was excluded, including first-generation antipsychotics (chlorpromazine, haloperidol, loxapine, thioridazine), two or more second-generation antipsychotics (amisulpride, aripiprazole, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone, or use of high-dose benzodiazepines (diazepine>=30 mg/day, clonazepam>=2 mg/day, lorazepam>=4 mg/day, alprazolam>=2 mg/day). Additional exclusion criteria were substance abuse, defined as any of the following behaviors in the prior 12 months: 5+ alcoholic drinks in a single day, use of prescription drugs for non-medical use, use of illicit drugs, to avoid potential confounding effects on vocal production ( 57 , 58 ).…”

Section: Methodsmentioning

confidence: 99%

Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study

Larsen,

Murton,

Song

et al. 2024

Front. Psychiatry

View full text Add to dashboard Cite

BackgroundThe utility of vocal biomarkers for mental health assessment has gained increasing attention. This study aims to further this line of research by introducing a novel vocal scoring system designed to provide mental fitness tracking insights to users in real-world settings.MethodsA prospective cohort study with 104 outpatient psychiatric participants was conducted to validate the “Mental Fitness Vocal Biomarker” (MFVB) score. The MFVB score was derived from eight vocal features, selected based on literature review. Participants’ mental health symptom severity was assessed using the M3 Checklist, which serves as a transdiagnostic tool for measuring depression, anxiety, post-traumatic stress disorder, and bipolar symptoms.ResultsThe MFVB demonstrated an ability to stratify individuals by their risk of elevated mental health symptom severity. Continuous observation enhanced the MFVB’s efficacy, with risk ratios improving from 1.53 (1.09-2.14, p=0.0138) for single 30-second voice samples to 2.00 (1.21-3.30, p=0.0068) for data aggregated over two weeks. A higher risk ratio of 8.50 (2.31-31.25, p=0.0013) was observed in participants who used the MFVB 5-6 times per week, underscoring the utility of frequent and continuous observation. Participant feedback confirmed the user-friendliness of the application and its perceived benefits.ConclusionsThe MFVB is a promising tool for objective mental health tracking in real-world conditions, with potential to be a cost-effective, scalable, and privacy-preserving adjunct to traditional psychiatric assessments. User feedback suggests that vocal biomarkers can offer personalized insights and support clinical therapy and other beneficial activities that are associated with improved mental health risks and outcomes.

show abstract

Section: Eligibility Criteriamentioning

confidence: 99%

Validating the efficacy and value proposition of Mental Fitness Vocal Biomarkers in a psychiatric population: prospective cohort study

Larsen,

Murton,

Song

et al. 2023

Preprint

View full text Add to dashboard Cite

This study represents a practical advancement in the application of vocal biomarkers for mental health tracking in real-world settings. Through a prospective cohort study involving 104 participants from an outpatient psychiatric population, we introduced a novel “Mental Fitness Vocal Biomarker” (MFVB) score, derived from eight preselected vocal features supported by literature review. Our findings demonstrate the MFVB’s efficacy in objectively stratifying individuals based on risk for elevated mental health symptom severity using the M3 Checklist for transdiagnostic assessment (depression, anxiety, post-traumatic stress disorder, and bipolar) as reference standard. Continuous observation over time significantly improves efficacy, yielding a risk ratio of 1.53 (1.09-2.14, p=0.0138) for single 30-second voice samples to 2.00 (1.21-3.30, p=0.0068) for 2-week aggregations, depending on MFVB score. Notably, in the highly engaged subgroup (5-6 MFVB uses per week, 38% of participants), a risk ratio of 8.50 (2.31-31.25, p=0.0013) was observed, underscoring the utility of frequent and continuous observation. Participant feedback confirmed the user-friendliness of the application and perceived benefits, highlighting the MFVB’s potential as a cost-effective, scalable, and privacy-preserving adjunct to traditional psychiatric assessments. These results establish that vocal biomarkers are a promising tool for objective mental health tracking in real-world conditions, offering personalized insights into users’ mental well-being as they engage with clinical therapy or other beneficial activities that are associated with improved mental health risks and outcomes.

show abstract

Uso de substâncias psicoativas, alterações vocais e qualidade de vida em usuários de drogas lícitas e ilícitas

Cited by 14 publications

References 27 publications

Fatores associados às queixas vocais autorreferidas por agentes comunitários de saúde

Fatores associados às queixas vocais autorreferidas por agentes comunitários de saúde

Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study

Validating the efficacy and value proposition of Mental Fitness Vocal Biomarkers in a psychiatric population: prospective cohort study

Contact Info

Product

Resources

About